QQ客服 官方微博 反馈留言

	Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non-Small Cell Lung Cancer Patients.
	Yang, Zhe; Yang, Nong; Ou, Qiuxiang; Xiang, Yi; Jiang, Tao; Wu, Xue; Bao, Hua; Tong, Xiaoling; Wang, Xiaonan; Shao, Yang W.
刊名	Clinical Cancer Research
	2018
卷号	24期号:13页码:3097-3107
ISSN号	1078-0432
DOI	10.1158/1078-0432.CCR-17-2310
URL标识	查看原文
WOS记录号	WOS:000437270800016
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3317645
专题	中南大学
作者单位	[Yang, Zhe] Shandong Univ, Shandong Prov Hosp, Tumor Res & Therapy Ctr, Jinan, Shandong, Peoples R China.
推荐引用方式 GB/T 7714	Yang, Zhe,Yang, Nong,Ou, Qiuxiang,et al. Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non-Small Cell Lung Cancer Patients.[J]. Clinical Cancer Research,2018,24(13):3097-3107.
APA	Yang, Zhe.,Yang, Nong.,Ou, Qiuxiang.,Xiang, Yi.,Jiang, Tao.,...&Zhou, Caicun*.(2018).Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non-Small Cell Lung Cancer Patients..Clinical Cancer Research,24(13),3097-3107.
MLA	Yang, Zhe,et al."Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non-Small Cell Lung Cancer Patients.".Clinical Cancer Research 24.13(2018):3097-3107.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。